HLA DRB1 Alleles and Hepatitis C Virus Infection in Chronic Kidney Disease Patients

REFERENCES

• Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet. 2003;362:2095–2100.
   PubMed Web of Science ®Google Scholar
• Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436–2441.
   PubMed Web of Science ®Google Scholar
• Thurairajah PH, Hegazy D, Chokshi S, . Hepatitis C virus (HCV)-specific T cell responses in injection drug users with apparent resistance to HCV infection. J Infect Dis. 2008;198(12):1749–1755.
   PubMedGoogle Scholar
• Plancoulaine S, Mohamed MK, Arafa N, . Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut. 2008;57(9):1268–1274.
   PubMedGoogle Scholar
• Perrella A, Grattacaso S, d’Antonio A, . Evidence of hepatitis C virus-specific interferon gamma-positive T cells in health care workers in an infectious disease department. Am J Infect Control. 2009;37(5):426–429.
   PubMedGoogle Scholar
• Kubitschke A, Bahr MJ, Aslan N, . Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viremia. Eur J Clin Invest. 2007;37(1):54–64.
   PubMedGoogle Scholar
• Bronowicki JP, Vetter D, Uhl G, . Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J Infect Dis. 1997;176:518–522.
   PubMedGoogle Scholar
• Koziel MJ, Wong DK, Dudley D, Houghton M, Walker BD. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis. 1997;176:859–866.
   PubMed Web of Science ®Google Scholar
• Al-Sherbiny M, Osman A, Mohamed N, . Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am J Trop Med Hyg. 2005;73:44–49.
   PubMedGoogle Scholar
• Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Microbiol Rev. 2009;22(2):370–385.
   PubMed Web of Science ®Google Scholar
• Verdon R, Pol S, Landais P, . Absence of association between HLA antigens and chronicity of viral hepatitis in hemodialyzed patients. J Hepatol. 1994;21(3):388–393.
   PubMedGoogle Scholar
• Congia M, Clemente MG, Dessi C, . HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology. 1996;24(6):1338–1341.
   PubMed Web of Science ®Google Scholar
• Kuniholm MH, Kovacs A, Gao X, . Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology. 2010;51(5):1514–1522.
   PubMedGoogle Scholar
• Hassan NF, El Ghorab NM, Abdel Rehim MS, . HIV infection in renal dialysis patients in Egypt. AIDS. 1994;8(6):853.
   PubMedGoogle Scholar
• Hassan AA, Khalil R. Hepatitis C in dialysis patients in Egypt: relationship to dialysis duration, blood transfusion, and liver disease. Saudi J Kidney Dis Transpl. 2000;11:72–73.
   PubMedGoogle Scholar
• Hraber P, Kuiken C, Yusim K. Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection. Hepatology. 2007;46(6):1713–1721.
   PubMedGoogle Scholar
• Neumann-Haefelin C, Thimme R. Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection. Genes Immun. 2007;8(3):181–192.
   PubMedGoogle Scholar
• Chen DF, Endres W, Kliem V, . No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease. Liver. 1996;16(6):384–389.
   PubMedGoogle Scholar
• Dinçer D, Besisik F, Oğuz F, . Genes of major histocompatibility complex class II influence chronic C hepatitis treatment with interferon in hemodialysis patients. Int J Artif Organs. 2001;24(4):212–214.
   PubMedGoogle Scholar
• Nolan D, Gaudieri S, Mallal S. Host genetics and viral infections: immunology taught by viruses, virology taught by the immune system. Curr Opin Immunol. 2006;18:413–421.
   PubMedGoogle Scholar
• Sulowicz W, Radziszewski A, Chowaniec E. Hepatitis C virus infection in dialysis patients. Hemodial Int. 2007;11(3):286–295.
   PubMedGoogle Scholar
• NIH Consensus Statement on Management of Hepatitis C. NIH Consens State Sci Statements. 2002;19(3):1–46.
   Google Scholar
• Faustini A, Colais P, Fabrizi E, . Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups. BMC Infect Dis. 2010;10:97.
   PubMedGoogle Scholar
• Zekri AR, El-Mahallawy HA, Hassan A, . HLA alleles in Egyptian HCV genotype-4 carriers. Egypt J Immunol. 2005;12(1):77–86.
   PubMedGoogle Scholar
• Hadhoud A, Abdulaziz AM, Menawi LA, . The relationship between HLA typing and HCV infection and outcome of renal transplantation in HCV positive patients. Exp Clin Transplant. 2003;1(1):19–25.
   PubMedGoogle Scholar
• Thurairajah PH, Hegazy D, Demaine A, Kaminski ER, Cramp ME. Loss of virus-specific T-cell responses in HCV exposed uninfected injection drug users with drug rehabilitation. J Infect Dis. 2011;203(6):847–853.
   PubMedGoogle Scholar
• Warshow UM, Riva A, Hegazy D, . Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection. J Viral Hepat. 2012;19(7):501–508.
   PubMedGoogle Scholar
• Knapp S, Warshow U, Ho KM, . A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection. Gastroenterology. 2011;141(1):320–325.
   PubMedGoogle Scholar